Kinga G. Blecharz
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
In vivo demonstration of blood-brain barrier impairment in Moyamoya disease.
Journal: Acta neurochirurgica
Published: November 15, 2018
GEN-O-MA project: an Italian network studying clinical course and pathogenic pathways of moyamoya disease-study protocol and preliminary results.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 27, 2018
Intravascular Inflammation Triggers Intracerebral Activated Microglia and Contributes to Secondary Brain Injury After Experimental Subarachnoid Hemorrhage (eSAH).
Journal: Translational stroke research
Published: July 11, 2016
Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: July 07, 2016
Vasculogenic and Angiogenic Pathways in Moyamoya Disease.
Journal: Current medicinal chemistry
Published: September 17, 2015
Control of the blood-brain barrier function in cancer cell metastasis.
Journal: Biology of the cell
Published: February 02, 2015
Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.
Journal: Cellular and molecular life sciences : CMLS
Published: April 24, 2014
Inhibition of proteasome-mediated glucocorticoid receptor degradation restores nitric oxide bioavailability in myocardial endothelial cells in vitro.
Journal: Biology of the cell
Published: November 28, 2013
TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy.
Journal: International journal of cardiology
Published: June 11, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026